BioNTech SE (BNTX)
NASDAQ: BNTX · Real-Time Price · USD
96.96
+4.90 (5.32%)
At close: Oct 9, 2026, 4:00 PM EDT
96.81
-0.15 (-0.15%)
After-hours: Oct 9, 2026, 7:33 PM EDT

BioNTech SE Stock Forecast

Stock Price Forecast

According to 21 analysts polled by S&P Global, BioNTech SE stock has a consensus rating of "Buy" and an average price target of $116.31. The average 1-year stock price forecast is 19.96% higher than the current stock price, while the lowest is $76.11 (-21.50%) and the highest is $144.22 (+48.74%).

Price Target: $116.31 (+19.96%)
Analyst Consensus: Buy

Price Target

Chart
TargetLowAverageMedianHigh
Price$76.11$116.31$123.13$144.22
Change-21.50%+19.96%+26.99%+48.74%

Analyst Ratings

The average analyst rating for BioNTech SE stock is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Chart
RatingMay '26Jun '26Jul '26Aug '26Sep '26Oct '26
Strong Buy131414141313
Buy111111
Hold555457
Sell000110
Strong Sell000000
Total192020202021

Latest Forecasts

AnalystFirmRatingRatingActionPrice TargetUpsideDate
Bank of America Securities
Bank of America Securities
Buy
Reiterates
$122 → $114
BuyReiterates$122 → $114+17.57%Oct 9, 2026
Argus Research
Argus Research
Hold
Initiates
n/a
HoldInitiatesn/an/aOct 8, 2026
Berenberg Bank
Berenberg Bank
Buy
Maintains
$140
BuyMaintains$140+44.39%Oct 7, 2026
Canaccord Genuity
Canaccord Genuity
Buy
Maintains
$136
BuyMaintains$136+40.26%Oct 6, 2026
Morgan Stanley
Morgan Stanley
Buy
Maintains
$114
BuyMaintains$114+17.57%Oct 5, 2026
More Analyst Ratings

Financial Forecast

Revenue This Year
1.79B
from 2.87B
Decreased by -37.73%
Revenue Next Year
1.80B
from 1.79B
Increased by 0.51%
EPS This Year
-4.78
from -0.48
EPS Next Year
-4.89
from -4.78
Fiscal YearFY 2021FY 2022FY 2023FY 2024FY 2025FY 2026
Period EndingDec 31, 2021Dec 31, 2022Dec 31, 2023Dec 31, 2024Dec 31, 2025Dec 31, 2026
Revenue
18.98B17.31B3.82B2.75B2.87B1.79B
Revenue Growth
3,834.63%-8.78%-77.94%-27.96%4.32%-37.73%
Gross Profit
16.07B14.32B3.22B2.21B2.26B1.43B
Gross Margin
84.66%82.70%84.29%80.32%78.70%80.09%
Operating Income
14.85B11.92B971.80M-1.29B-1.27B-1.86B
Net Income
10.29B9.43B930.30M-665.30M-1.14B-1.43B
EPS
-----0.48-4.78
Free Cash Flow
----280.90M-1.75B
No. Analysts
-----18
EPS and Forward PE are based on non-GAAP adjusted numbers. Financial currency is EUR.

Revenue Forecast

Revenue202620272028
High1.9B
Avg1.8B
Low1.7B

Revenue Growth

Revenue Growth202620272028
High
-33.0%
Avg
-37.7%
Low
-42.4%

EPS Forecast

EPS202620272028
High-4.11
Avg-4.78
Low-6.61

EPS Growth

EPS Growth202620272028
High-
Avg-
Low-